
Nephros NEPH
$ 4.98
-0.8%
Quarterly report 2025-Q3
added 11-06-2025
Nephros ROE Ratio 2011-2025 | NEPH
Annual ROE Ratio Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.84 | -127.07 | -33.07 | -38.06 | -73.16 | -89.57 | -41.49 | -454.57 | -115.92 | 129.75 | 606.23 | 548.24 | -166.08 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 606.23 | -454.57 | 9.72 |
Quarterly ROE Ratio Nephros
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.08 | 12.95 | 6.84 | -3.47 | -5.58 | -9.93 | -11.29 | -10.55 | -43.47 | -74.28 | -78.39 | -56.71 | -64.68 | -39.73 | -38.13 | -18.94 | -27.02 | -27.13 | -32.85 | -30.08 | -46.0 | -53.83 | -60.75 | -64.92 | -79.82 | -78.81 | -76.62 | -70.48 | -102.89 | -120.4 | -142.75 | -107.59 | -213.44 | -286.87 | -371.75 | -356.37 | -378.18 | -294.14 | -237.09 | -80.82 | -128.75 | -154.87 | 7.24 | 107.85 | 502.6 | 945.29 | 1060.98 | 356.23 | 499.59 | 248.2 | 165.25 | 363.7 | 334.63 | 162.21 | -6.88 | -121.18 | -29.06 | -42.36 | -49.75 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1060.98 | -378.18 | 7.78 |
ROE Ratio of other stocks in the Medical instruments industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
-5.78 | $ 24.59 | 0.82 % | $ 1.13 B | ||
|
Baxter International
BAX
|
-7.35 | $ 19.67 | 2.72 % | $ 10 B | ||
|
Becton, Dickinson and Company
BDX
|
6.61 | $ 200.94 | 0.02 % | $ 57.8 B | ||
|
Harvard Bioscience
HBIO
|
-4.67 | $ 0.71 | -4.79 % | $ 30.1 M | ||
|
Luminex Corporation
LMNX
|
2.93 | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
-5.99 | $ 148.26 | -0.11 % | $ 3.62 B | ||
|
iRhythm Technologies
IRTC
|
-124.62 | $ 171.15 | 1.37 % | $ 5.34 B | ||
|
Akers Biosciences, Inc.
AKER
|
-50.84 | - | -9.52 % | $ 20.6 M | ||
|
Repro Med Systems
KRMD
|
-67.51 | $ 5.8 | 0.35 % | $ 264 M | ||
|
LeMaitre Vascular
LMAT
|
13.06 | $ 82.87 | -1.35 % | $ 1.86 B | ||
|
Ekso Bionics Holdings
EKSO
|
-89.16 | $ 4.75 | 1.61 % | $ 95.8 M | ||
|
Masimo Corporation
MASI
|
-28.99 | $ 137.05 | -0.93 % | $ 7.3 B | ||
|
Merit Medical Systems
MMSI
|
8.73 | $ 86.58 | -0.14 % | $ 5.04 B | ||
|
Antares Pharma, Inc.
ATRS
|
47.18 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.88 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-23.1 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
12.92 | - | -0.05 % | $ 10.3 B | ||
|
OraSure Technologies
OSUR
|
-4.75 | $ 2.49 | -0.2 % | $ 185 M | ||
|
Varian Medical Systems, Inc.
VAR
|
16.51 | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
-2.82 | $ 79.08 | 0.36 % | $ 40.4 B | ||
|
ResMed
RMD
|
23.19 | $ 251.83 | -0.17 % | $ 36.8 B | ||
|
AtriCure
ATRC
|
-9.7 | $ 41.24 | -2.69 % | $ 1.94 B | ||
|
Atrion Corporation
ATRI
|
7991.72 | - | - | $ 810 M | ||
|
electroCore
ECOR
|
-253.08 | $ 4.88 | 2.77 % | $ 26.9 K | ||
|
AngioDynamics
ANGO
|
-18.58 | $ 13.41 | 2.05 % | $ 548 M | ||
|
The Cooper Companies
COO
|
4.55 | $ 81.08 | -1.22 % | $ 16.1 B | ||
|
STAAR Surgical Company
STAA
|
-5.09 | $ 23.5 | -2.61 % | $ 1.15 B | ||
|
STERIS plc
STE
|
9.31 | $ 254.36 | 1.02 % | $ 25.1 B | ||
|
Stereotaxis
STXS
|
-126.74 | $ 2.35 | -1.05 % | $ 190 M | ||
|
Glaukos Corporation
GKOS
|
-29.16 | $ 112.01 | 2.87 % | $ 5.42 B | ||
|
Haemonetics Corporation
HAE
|
20.43 | $ 79.28 | -5.04 % | $ 3.99 B | ||
|
InfuSystem Holdings
INFU
|
0.04 | $ 9.19 | -0.54 % | $ 190 M | ||
|
Isoray
ISR
|
-27.27 | - | 0.03 % | $ 108 M | ||
|
Utah Medical Products
UTMD
|
3.34 | $ 57.28 | -1.41 % | $ 208 M | ||
|
Intuitive Surgical
ISRG
|
14.13 | $ 559.74 | 3.21 % | $ 199 B | ||
|
DENTSPLY SIRONA
XRAY
|
-46.86 | $ 11.34 | -1.99 % | $ 2.3 B | ||
|
Microbot Medical
MBOT
|
-238.61 | $ 2.25 | -6.64 % | $ 22.9 M | ||
|
Milestone Scientific
MLSS
|
-80.81 | $ 0.36 | -8.72 % | $ 28.7 M | ||
|
NeuroMetrix
NURO
|
-54.54 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
-38.12 | $ 22.11 | 0.61 % | $ 3.81 B | ||
|
Pro-Dex
PDEX
|
24.51 | $ 44.15 | 1.78 % | $ 145 M | ||
|
Pulse Biosciences
PLSE
|
-95.15 | $ 14.11 | -0.91 % | $ 678 M | ||
|
Predictive Oncology
POAI
|
6250.62 | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
1.81 | $ 160.25 | 1.82 % | $ 8.93 M | ||
|
Retractable Technologies
RVP
|
-13.64 | $ 0.84 | 1.99 % | $ 25.1 M | ||
|
Teleflex Incorporated
TFX
|
1.63 | $ 126.53 | -0.11 % | $ 5.93 B | ||
|
West Pharmaceutical Services
WST
|
18.37 | $ 271.88 | 1.62 % | $ 19.8 B |